The influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats

Acta Medica Okayama

Volumn 61, Issue 6, 2007, Pages 311-317

  Umeda, Yuichi ^a   Amano, Manabu ^b   Suemaru, Katsuya ^a   Yamaguchi, Takumi ^a   Kitamura, Yoshihisa ^c   Gomita, Yutaka ^c   Kawasaki, Hiromu ^b   Araki, Hiroaki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

5 HT2A receptor; ACTH; Dexamethasone; Hyperglycemia; Streptozotocin

Indexed keywords

CANIS FAMILIARIS; RATTUS;

CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID; HORMONE; SEROTONIN 2A RECEPTOR; STREPTOZOCIN;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HYPERGLYCEMIA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; STEREOTYPY; WISTAR RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BEHAVIOR, ANIMAL; DEXAMETHASONE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOCORTICOIDS; HORMONES; HYPERGLYCEMIA; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; STEREOTYPED BEHAVIOR; STREPTOZOCIN;

EID: 39049143328     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Anderson RJ, Freedland KE, Clouse RE and Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 24: 1069-1078.
2. Cameron OG, Kronfol Z, Greden JF and Carroll BJ: Hypothalamic-pituitary- adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry (1984) 41: 1090-1095.
3. Roy M, Collier B and Roy A: Hypothalamic-pituitary-adrenal axis dysregulation among diabetic out-patients. Psychiatry Res (1990) 31: 31-37.
4. Brown ES, Suppes T, Khan DA and Carmody TJ 3rd: Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol (2002) 22: 55-61.
5. Klein-Gitelman MS and Pachman LM: Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol (1998) 25: 1995-2002.
6. Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR and Horton RW: Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Res (1997) 769: 135-140.
7. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ and Mann JJ: Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry (1990) 47: 1038-1047.
8. Kitamura Y, Araki H and Gomita Y: Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav (2002) 71: 63-69.
9. Kitamura Y, Araki H, Suemaru K and Gomita Y: Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats. Pharmacol Biochem Behav (2002) 72: 397-402.
10. 2A Receptor-mediated Wet-dog Shake Responses in Streptozotocin-induced Diabetic Rats. Acta Med Okayama (2007) 61: 205-212.
11. Suemaru K, Gomita Y, Furuno K and Araki Y: Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats. Pharmacol Biochem Behav (1993) 46: 135-139.
12. Jitsuiki H, Kagaya A, Goto S, Horiguchi J and Yamawaki S: Effect of lithium carbonate on the enhancement of serotonin 2A receptor elicited by dexamethasone. Neuropsychobiology (2000) 41: 55-61.
13. Amatruda JM, Livingston JN and Lockwood DH: Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure. Diabetes Metab Rev (1985) 1: 293-317.
14. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM and Imbimbo B: An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest (1983) 72: 1814-1820.
15. Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S and Okret S: Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest (1997) 100: 2094-2098.
16. Chan O, Inouye K, Vranic M and Matthews SG: Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology (2002) 143: 1761-1768.
17. de Kloet ER, Reul JM and Sutanto W: Corticosteroids and the brain. J Steroid Biochem Mol Biol (1990) 37: 387-394.
18. Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H and Macher JP: Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry (2000) 24: 207-225.
19. Hall RCW, Popkin MK and Kirkpatrick B: Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis (1978) 166: 738-742.
20. Ling MHM, Perry PJ and Tsuang MT: Side effects of corticosteroid therapy, Psychiatric aspects. Arch Gen Psychiatry (1981) 38: 471-477.
21. Wrobel A, Zebrowska-Lupina I and Wielosz M: Dexamethasone reduces locomotor stimulation induced by dopamine agonists in mice. Pharmacol Rep (2005) 57: 451-457.
22. Danilczuk Z, Ossowska G, Wrobel A and Lupina T: Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats. Pol J Pharmacol (2001) 53: 467-473.
23. Lim DK, Lee KM and Ho IK: Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch Pharm Res (1994) 17: 398-404.
24. Murzi E, Contreras Q, Teneud L, Valecillos B, Parada MA, De Parada MP and Hernandez L: Diabetes decreases limbic extracellular dopamine in rats. Neurosci Lett (1996) 202: 141-144.
25. Sumiyoshi T, Ichikawa J and Meltzer HY: The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain. Neuropsychopharmacology (1997) 16: 183-190.
26. Suemaru K, Araki H, Kitamura Y, Yasuda K and Gomita Y: Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats. Psychopharmacology (Berl) (2001) 159: 38-41.
27. Willins DL and Meltzer HY: Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther (1997) 282: 699-706.
28. Kawakami Y, Kitamura Y, Araki H, Kitagawa K, Suemaru K, Shibata K and Gomita Y: Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats. Pharmacol Biochem Behav (2005) 81: 65-70.
29. Katagiri H, Kagaya A, Nakae S, Morinobu S and Yamawaki S: Modulation of serotonin2A receptor function in rats after repeated treatment with dexamethasone and L-type calcium channel antagonist nimodipine. Prog Neuropsychopharmacol Biol Psychiatry1 (2001) 25: 1269-1281.
30. Kuroda Y, Mikuni M, Ogawa T and Takahashi K: Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology (1992) 108: 27-32.
31. Kuroda Y, Mikuni M, Nomura N and Takahashi K: Differential effect of subchronic dexamethasone treatment on serotonin-2 and beta-adrenergic receptors in the rat cerebral cortex and hippocampus. Neurosci Lett (1993) 155: 195-198.
32. Reagan LP, Magarinos AM and McEwen BS: Neurological changes induced by stress in streptozotocin diabetic rats. Ann NY Acad Sci (1999) 893: 126-137.